Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1750-1326

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome ; volume:12 ; number:1 ; day:4 ; month:9 ; year:2017 ; pages:1-11 ; date:12.2017
Molecular neurodegeneration ; 12, Heft 1 (4.9.2017), 1-11, 12.2017

Keyword: Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit

Creator: Tatebe, Harutsugu

Contributor: Kasai, Takashi
Ohmichi, Takuma
Kishi, Yusuke
Kakeya, Tomoshi
Waragai, Masaaki
Kondō, Masaki
Allsop, David
Tokuda, Takahiko
SpringerLink (Online service)

DOI: 10.1186/s13024-017-0206-8

URN: urn:nbn:de:1111-2017110414788

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:35 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Tatebe, Harutsugu
Kasai, Takashi
Ohmichi, Takuma
Kishi, Yusuke
Kakeya, Tomoshi
Waragai, Masaaki
Kondō, Masaki
Allsop, David
Tokuda, Takahiko
SpringerLink (Online service)

Other Objects (12)

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

Scientific commentary on: “Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer’s disease and primary tauopathies”

Propagation of Tau pathology in Alzheimer disease

Biological mechanisms of resilience to tau pathology in Alzheimer’s disease

Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative

Phosphorylated tau in cerebrospinal fluid-derived extracellular vesicles in Alzheimer’s disease: a pilot study

CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease

Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels

Molecular mechanisms of Tau and TDP-43 co-pathology in Alzheimer´s disease

Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization

Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

Scientific commentary on: “Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer’s disease and primary tauopathies”

Propagation of Tau pathology in Alzheimer disease

Biological mechanisms of resilience to tau pathology in Alzheimer’s disease

Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative

Phosphorylated tau in cerebrospinal fluid-derived extracellular vesicles in Alzheimer’s disease: a pilot study

CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease

Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels

Molecular mechanisms of Tau and TDP-43 co-pathology in Alzheimer´s disease

Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization

Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

Scientific commentary on: “Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer’s disease and primary tauopathies”

Propagation of Tau pathology in Alzheimer disease

Biological mechanisms of resilience to tau pathology in Alzheimer’s disease

Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative

Phosphorylated tau in cerebrospinal fluid-derived extracellular vesicles in Alzheimer’s disease: a pilot study

CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease

Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels

Molecular mechanisms of Tau and TDP-43 co-pathology in Alzheimer´s disease

Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization

Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

Scientific commentary on: “Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer’s disease and primary tauopathies”

Propagation of Tau pathology in Alzheimer disease

Biological mechanisms of resilience to tau pathology in Alzheimer’s disease

Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative

Phosphorylated tau in cerebrospinal fluid-derived extracellular vesicles in Alzheimer’s disease: a pilot study

CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease

Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels

Molecular mechanisms of Tau and TDP-43 co-pathology in Alzheimer´s disease

Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization

Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

Scientific commentary on: “Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer’s disease and primary tauopathies”

Propagation of Tau pathology in Alzheimer disease

Biological mechanisms of resilience to tau pathology in Alzheimer’s disease

Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative

Phosphorylated tau in cerebrospinal fluid-derived extracellular vesicles in Alzheimer’s disease: a pilot study

CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease

Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels

Molecular mechanisms of Tau and TDP-43 co-pathology in Alzheimer´s disease

Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization

Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

Scientific commentary on: “Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer’s disease and primary tauopathies”

Propagation of Tau pathology in Alzheimer disease

Biological mechanisms of resilience to tau pathology in Alzheimer’s disease

Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative

Phosphorylated tau in cerebrospinal fluid-derived extracellular vesicles in Alzheimer’s disease: a pilot study

CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease

Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels

Molecular mechanisms of Tau and TDP-43 co-pathology in Alzheimer´s disease

Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization

Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease

Related objects

Reset password